EIP
CELG

Ellis Investment Partners’s Celgene Corp CELG Stock Holding History

Ellis Investment Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-560
Closed -$55K – 737
2019
Q3 		$55K Hold
560
– – 0.02% 323
2019
Q2 		$52K Sell
560
-13,187
-96% -$1.25M 0.02% 323
2019
Q1 		$1.29M Sell
13,747
-260
-2% -$22.7K 0.52% 46
2018
Q4 		$892K Buy
+14,007
New +$1.03M 0.41% 54

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Ellis Investment Partners's CELG Position: Q4 2019 in Review

Ellis Investment Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 560 shares — an estimated $55K sold.

Ellis Investment Partners first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $1.29M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Ellis Investment Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Ellis Investment Partners sold 560 Celgene Corp shares in Q4 2019, an estimated $55K.
  • Ellis Investment Partners first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Ellis Investment Partners's Celgene Corp position peaked at $1.29M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Ellis Investment Partners's 13F filing for Q4 2019, filed 7 Jan 2020.